Removing all visible cancer is key to treating aggressive brain tumors

September 15, 2015
Removing all visible cancer is key to treating aggressive brain tumors
Study of almost 100 children also finds greater survival rate for girls than boys after surgery.

(HealthDay)—Surgery that removes all visible cancer significantly improves the chances of survival for children with aggressive brain tumors, especially girls.

That's the finding of a study that included almost 100 children treated for high-grade glioma between 1988 and 2010. These rare brain tumors occur in fewer than one in 100,000 children and teens.

After two years, the overall survival rate was 45 percent; 25 percent had no cancer progression.

Surgery to remove all visible signs of cancer was successful in one-third of the children. Their median survival was 3.4 years, compared with 1.6 years for those who did not have all visible cancer removed. Median means half of the children lived longer, half did not.

The after successful surgery was much greater in girls, with median survival of 8.1 years. Boys had a median survival of 2.4 years.

The study is published in the September issue of the journal Neurosurgery.

Surgical removal of all visible cancer is already the standard of care, but this study reinforces its importance in improving survival, according to Dr. Jeffrey Greenfield and colleagues. Greenfield is an associate professor of neurological surgery at Weill Cornell Medical College in New York City.

High-grade gliomas account for 8 percent to 12 percent of brain tumors in children, and about 30 percent of in adults.

Explore further: Complete resection of high-grade brain cancer yields better survival in children—especially girls

More information: The U.S. National Library of Medicine has more about childhood brain tumors.

Related Stories

Complete resection of high-grade brain cancer yields better survival in children—especially girls

August 18, 2015
For children with aggressive brain cancers called high-grade gliomas (HGG), the chances of survival are improved when surgery is successful in eliminating all visible cancer, reports a study in the September issue of Neurosurgery, ...

Gender influences survival after pediatric brain tumor removal

August 26, 2015
It's an unexpected discovery: All else being equal, girls whose rare and deadly brain tumors are fully removed live almost six years longer than boys with the same condition.

Improved survival in adult patients with low-grade brain tumors

July 1, 2015
Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving ...

Laparoscopic surgery achieves similar survival rates in rectal cancer

April 2, 2015
(HealthDay)—Patients with localized rectal cancer may achieve similar survival rates by having minimally invasive laparoscopic surgery, instead of more invasive open surgery, according to new research published in the April ...

Clinical trial suggests combination therapy is best for low-grade brain tumors

March 10, 2015
New clinical-trial findings provide further evidence that combining chemotherapy with radiation therapy is the best treatment for people with a low-grade form of brain cancer. The findings come from a phase II study co-led ...

When cancer makes its way to the brain

August 27, 2015
Only half of brain cancers actually start in the brain. The rest—as in the case of former President Jimmy Carter—are metastatic tumors from cancer that originated elsewhere in the body.

Recommended for you

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.